DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • IntuitiveTalks – How Curet and Duncan make the surgical robot case to surgeons and hospitals
    In the second episode of IntuitiveTalks, two senior executives explain how the company gets surgeons and hospitals to understand the benefits of the Da Vinci system.
    EVP Dr. Myriam Curet, who describes herself as a late adopter of technology, shares why she opted to join Intuitive as CMO early on after trying the Da Vinci robot.
    Similarly, SVP Gillian Duncan, who heads physician training and development, says her early experience with the robotic system convince her to leave her academic career to join the robotics pioneer.
    Subscribe to this podcast on all major podcast applications.
    37 min
  • NuVasive CEO Chris Barry positioning spinal pioneer for growth by embracing new digital technologies
    This week we’ll hear from Chris Barry, CEO of NuVasive. Barry joined NuVasive at a critical period in 2018. Now, the company is building out its portfolio of surgical tools, adding a digital surgery platform, planning its own move into robotics and finally making training much easier for its surgeons through new facilities, both real and virtual.
    Danielle Kirsh, senior editor, and Jim Hammerand, deliver the highlights from this month’s Medical Design and Outsourcing Magazine, our Women in Medtech issue. Danielle reveals some disheartening news about jobs and research dollars going to women while Jim shares hopeful details from some of the profiles.
    Chris Newmarker, executive editor, identifies this week’s Newmarker’s Newsmakers – Avail Medsystems, Integra Lifesciences, GE, Medtronic and NuVasive.
    Subscribe to this podcast on all major podcast applications.
    1 hr 3 min
  • Surgical Robotics & Beyond - Hugo Scores CE Mark; Is Zimmer Biomet morphing into a tech company?
    The surgical robots are back in this episode of the DeviceTalks Weekly Podcast. First we’ll speak with Megan Rosengarten, president of robotics at Medtronic, about what the CE Mark for the Hugo surgical robot system means for current and future applications.
    Then, we speak with Ivan Tornos, COO of Zimmer Biomet, about that company’s broad technology offerings include ZBEdge, PersonaIQ Knee Implant, and other digital data collectors. Tornos says Zimmer Biomet intends to be the boldest company in the medtech industry.
    Chris Newmarker is back to deliver this week’s Newmarker’s Newsmakers – Intuitive Surgical, Xenter, Moderna, Medtronic, and Johnson & Johnson.
    Associate Editor Sean Whooley joins in on the fun.
    Subscribe to this podcast on all major podcast applications.
    1 hr 9 min
  • Boston Scientific and Zenflow are bringing critical new tools to help urologists treat patients
    The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field. That puts the onus on medical device companies to develop faster, safer and more efficacious ways to break down kidney stones, shrink enlarged prostates and handle other critical treatments. In this week’s episode, we’ll speak with Meghan Scanlon, SVP and president, Urology and Pelvic Health at Boston Scientific about that company’s growing pipeline bolstered by the acquisition of Lumenis.
    This episode was sponsored by KNF Neuberger.
    We’ll also connect with the leaders of Zenflow – CEO Nick Damiano and President Susan Stimson – about the start-up’s minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH).
    Finally, we have all-hands (or most hands) on deck for this episodes Newmarker's Newsmakers. Jim Hammerand, managing editor of Medical Design and Outsourcing, talks about Koya Medical and Hologic. Associate Editor Sean Whooley shares his insights on Varian and Explorer Surgical. Pharma Editor Brian Buntz gives us the latest on the never ending saga of Covid-19 booster approval.
    Subscribe on all major podcast applications.
    1 hr 14 min
  • CEO Gary Guthart explains how Intuitive grew into the dominant force in surgical robotics
    In this first episode of the new IntuitiveTalks Podcast, we’ll start right at the beginning. CEO Gary S. Guthart recalls how a court side basketball conversation led to his introduction to the early form of a surgical robot and convinced him to join. He also shares his expectations for the surging surgical robotics field, including how the company will view emerging competition.
    This episode is sponsored by Tegra Medical.
    43 min
  • Stereotaxis, Levita Magnetics make attractive cases for magnet-powered surgical robot systems
    Get it? Attractive? Magnets. Yeh, we’ll, we’re tired from putting this monster podcast episode together but it’s so, so good.
    You’ll hear from David Fischel, CEO of Stereotaxis, a 30-plus year old medtech that’s going through a quiet but deliberate reboot. Fischel says he took the company over because Stereotaxis’ magnetic robotic surgery system makes interventional surgery safer, an assertion supported by Daniel Cooper, MD, associate professor at Washington University School of Medicine. Stereotaxis appears to be on the cusp of something big.
    Then, Alberto Rodriguez-Navarro, MD, tells us why he sold everything to move from his native Chile to move to Silicon Valley and start Levitra Magnetics. The company is anticipating FDA approval for its own robotic system that could help hospitals overcome staffing shortages during laparoscopic procedures.
    We’ll also hear our sponsor Futek explain how its miniaturized sensors are advancing robotic surgery.
    Chris Newmarker, executive editor of life sciences, delivers the week’s big news featuring Siemen Healthineers, LumiraDx, Boston Scientific, Abbott and Medtronic. Senior editor Danielle Kirsh updates us on the Theranos trial.
    Subscribe to this podcast on all major channels.
    1 hr 33 min
  • Visit the Osso VR ortho OR with CEO Barad; DePuy’s Peters sees growth in shoulder, spine, sports med
    This episode of the DeviceTalks Weekly Podcast draws from two realities
    First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company’s new Inhance Shoulder system will help the company grab market share in the increasingly competitive space.
    Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR’s virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance.
    Chris Newmarker, executive editor of life sciences, identifies this week’s Newmarker’s Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis.
    Subscribe to this podcast on all major channels!
    1 hr 18 min
  • How ResMed, Inspire Medical Woke Up Demand for Innovative Apnea Devices & Data
    Zoll Medical’s acquisition of Itamar Medical is just latest sign of the opportunity diagnosing and treating sleep apnea presents to medical device companies, especially following the CPAP machine recall issued by Philips Respironics earlier this summer.
    This week, we’ll talk with two of the leaders in this increasingly competitive market.
    First, we’ll reconnect with Tim Herbert, CEO of Inspire Medical Systems, to learn how that neurostimulation company is working to serve patients seeking an alternative to CPAP machines.
    This is our second visit with Tim Herbert. You can find his earlier interview on DeviceTalks.com.
    Then we welcome Michael “Mick” Farrell, CEO of ResMed, the leading provider of CPAP machines. Farrell explains why the apnea market is growing and what this means for the future of ResMed, which has grown into other respiratory businesses.
    Chris Newmarker returns! The executive editor of life sciences at MassDevice presents his Newmarker’s Newsmakers including Zoll, Itamar, Medtronic, Medicrea, iRhythm, Zimmer and its new spinout, ZimVie.
    We also discuss CMS’s disappointing backtrack on reimbursing innovative technologies.
    Danielle Kirsh, senior editor of life sciences, also presents a short report on the trial of Theranos founder Elizabeth Holmes.
    1 hr 12 min
  • The Complete History of the Sapien TAVR – from PVT’s Emerging Idea to Edwards Lifesciences' Success
    Edward Lifesciences’ acquisition of Percutaneous Valve Technologies helped mark the birth of one of medtech’s great game-changers – the development of the transcatheter aortic valve replacement.
    In this week’s episode, Stanton Rowe, the former CEO of PVT, will walk us through the early days of TAVR, including the enormous doubt the start-up faced as it developed the technology. He also explained how Edwards came to acquire the start-up, which had strong interest from Medtronic, Boston Scientific, and others.
    Rowe, who is now CEO of the NXT Biomedical incubator, also offers some provocative thoughts on the origins of medtech innovation (and explains why he misses medical device conferences.)
    Larry Wood, corporate vice president at Edwards Lifesciences, will explain why Edwards opted to pursue PVT rather than continue to develop its own TAVR technology.
    He also explains why the clinical trial testing of the valve now known as Sapien was so difficult and how he rewrote the compensation packages for his TAVR sales team to help build confidence in the new technology.
    Scan the QR code for more information about our upcoming DeviceTalks Tuesday discussion with Sagentia!
    You can subscribe to this podcast on most major podcast players including Amazon, Apple, Google, and Spotify.
    1 hr 29 min